youtube_live
Q3 2026 earnings • in 2 days
See detailschevron_right
VTR:NYSE
Ventas Inc
$86.80
arrow_downward
-0.22%(-0.19) 1D
$86.80
0.00% (0.00)
bedtimeAfter hours
Closed: Oct 23, 4:01:34 PM GMT-4 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VTR...
Open
$87.38
High
$87.90
Low
$86.16
Mkt. cap
44.52B
Avg. vol.
3.92M
Volume
2.46M
Dividend
2.35%
Quarterly dividend
$0.51
Ex-dividend date
Sep 30, 2026
P/E ratio
159.25
52-wk high
$101.60
52-wk low
$68.15
EPS
$0.55
Beta
0.71
Shares outstanding
512.95M
No. of employees
542
Open
$87.38
High
$87.90
Low
$86.16
Mkt. cap
44.52B
Avg. vol.
3.92M
Volume
2.46M
Dividend
2.35%
Quarterly dividend
$0.51
Ex-dividend date
Sep 30, 2026
P/E ratio
159.25
52-wk high
$101.60
52-wk low
$68.15
EPS
$0.55
Beta
0.71
Shares outstanding
512.95M
No. of employees
542
News stories
From web sources and news partners
Zacks
·
1 day ago
What's in the Offing for Ventas Stock This Earnings Season?
Yahoo Finance
·
2 days ago
Are You Looking for a High-Growth Dividend Stock?
Profile
Ventas, Inc. is a real estate investment trust specializing in the ownership and management of research, medicine and healthcare facilities in the United States, Canada and the United Kingdom.
As of December 2019, the group's portfolio consisted of 1,200 properties divided among nursing homes, medical office buildings, rehabilitation and acute care centres, special care centres, laboratories and research centres and medical-surgical centres for a total value of nearly $25 billion.
As of 2019, it is a Fortune 1000 corporation. Wikipedia
About Ventas Inc
CEODebra Cafaro
Employees542
Founded1983
HeadquartersChicago, Illinois, United States
SectorReal estate investment trust
Websiteventasreit.com
Analyst ratings
Based on 14 analysts giving stock ratings to VTR in the past 3 months
Buy
Buy
10
Hold
4
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for VTR in the last 3 months.
Highest
Current $86.80
$113.00 (+30.18%)
Average
$98.07 (+12.98%)
Lowest
$72.00 (-17.05%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
John Kilichowski Wells Fargo | Buy | Reiterated | $96.00 | +10.6% | 10/19/2026 |
Michael Goldsmith UBS | Hold | Maintained | $90.00 | +3.7% | 10/13/2026 |
Richard Hightower Barclays | Hold | Maintained | $91.00 | +4.8% | 10/13/2026 |
Juan C. Sanabria BMO Capital | Buy | Reiterated | $107.00 | +23.3% | 10/02/2026 |
James Kammert Evercore ISI | Buy | Maintained | $100.00 | +15.2% | 09/21/2026 |
Julien Blouin Goldman Sachs | Buy | Maintained | $112.00 | +29% | 09/16/2026 |
Joe Dickstein Jefferies | Buy | Initiated | $102.00 | +17.5% | 09/15/2026 |
Michael Mueller J.P. Morgan | Buy | Maintained | $104.00 | +19.8% | 09/03/2026 |
Nicholas Yulico Scotiabank | Hold | Maintained | $95.00 | +9.4% | 09/02/2026 |
Michael Carroll RBC Capital | Buy | Reiterated | $99.00 | +14.1% | 08/14/2026 |
Ronald Kamdem Morgan Stanley | Hold | Reiterated | $90.00 | +3.7% | 08/13/2026 |
Nicholas Joseph Citi | Buy | Maintained | $72.00 | -17.1% | 08/04/2026 |
Jeffrey Spector Bank of America Securities | Buy | Reiterated | $113.00 | +30.2% | 08/03/2026 |
Richard Anderson Cantor Fitzgerald | Buy | Reiterated | $102.00 | +17.5% | 07/31/2026 |
Vikram Malhotra Mizuho Securities | Buy | Maintained | $104.00 | +19.8% | 07/22/2026 |
Unknown Analyst Wells Fargo | Buy | Reiterated | $114.00 | +31.3% | 07/15/2026 |
Unknown Analyst Raymond James | Buy | Initiated | $94.00 | +8.3% | 06/16/2026 |
Dave Rodgers Raymond James | Buy | Initiated | $94.00 | +8.3% | 06/16/2026 |
Omotayo Okusanya Deutsche Bank | Buy | Maintained | $100.00 | +15.2% | 06/16/2026 |
Jonathan Petersen Jefferies | Buy | Maintained | $100.00 | +15.2% | 05/12/2026 |
Austin Wurschmidt KeyBanc | Buy | Maintained | $95.00 | +9.4% | 05/07/2026 |
Marie Ferguson Argus Research | Buy | Maintained | $88.00 | +1.4% | 02/09/2026 |
Next call in 2 days
Tue, Oct 27, 10:00 AM
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
- / $0.11
Revenue / Est. (USD)
- / 1.78B
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
Revenue | 1.50B | 1.55B | 1.65B | 1.72B |
Cost of goods sold | 869.92M | 937.40M | 1.00B | 1.04B |
Cost of revenue | 869.92M | 937.40M | 1.00B | 1.04B |
Research and development expenses | - | - | - | - |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 40.39M | 41.01M | 62.75M | 46.99M |
Operating expense | 397.56M | 297.53M | 416.91M | 422.70M |
Total operating expenses | 1.27B | 1.23B | 1.42B | 1.47B |
Operating income | 233.98M | 315.49M | 226.81M | 254.70M |
Other non operating income | -13.37M | -4.20M | -9.70M | -4.45M |
EBT including unusual items | 62.36M | 71.87M | 43.11M | 46.60M |
EBT excluding unusual items | 66.67M | 164.69M | 63.47M | 91.99M |
Income tax expense | -6.34M | -1.12M | -15.94M | -25.62M |
Effective tax rate | -10.17% | -1.56% | -36.97% | -54.97% |
Other operating expenses | - | - | - | - |
Net income | 66.05M | 70.20M | 55.91M | 70.57M |
Net profit margin | 4.40% | 4.53% | 3.39% | 4.10% |
Earnings per share | 0.12 | 0.13 | 0.10 | 0.17 |
Interest and investment income | 4.18M | 7.88M | 2.50M | 1.78M |
Interest expense | -158.12M | -154.47M | -156.14M | -160.03M |
Net interest expenses | -153.94M | -146.59M | -153.64M | -158.26M |
Depreciation and amortization charges | 357.17M | 256.52M | 354.17M | 375.71M |
EBITDA | 559.73M | 659.02M | 585.75M | 633.56M |
Gain or loss from assets sale | -1.28M | -3.31M | -15.06M | -174.00K |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1